Price movement over the last 24 hours
ARK Genomic Revolution ETF vs iShares MSCI South Africa ETF — how do they compare? ARK Genomic Revolution ETF trades at $40.83, while iShares MSCI South Africa ETF trades at $63.82. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, iShares MSCI South Africa ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | EZA | |
|---|---|---|
Sector | Sector/Thematic | Broad Market / Factor |
52-Week High | $43.57 | $81.60 |
52-Week Low | $23.09 | $52.86 |
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
EZA trades at $63.82, up 0.85% today, but technical indicators show a bearish trend with all 13 moving averages signaling sell. The stock faces resistance at $64 and support at $61. Recent news highlights South Africa's extended fuel tax cuts through June 2026, which may impact energy sector dynamics. Financial ratios including P/E, P/S, and ROE are unavailable, limiting fundamental clarity.
Outlook remains cautious due to bearish technicals and lack of current financial data. Risks include reliance on African mineral demand and geopolitical factors. Investors should await updated earnings reports for valuation insights, as the neutral sentiment from oscillators suggests limited near-term momentum.
Trailing returns across standard periods
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →EZA is a country-specific ETF that tracks the South African equity market. It provides exposure to large and mid-cap companies across key sectors like materials and financials, with top holdings such as AngloGold Ashanti and Naspers.
Read more on EZA →